These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1928061)

  • 1. Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia.
    Salem MM; Rosa RM; Batlle DC
    Am J Kidney Dis; 1991 Oct; 18(4):421-40. PubMed ID: 1928061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease.
    Allon M; Dansby L; Shanklin N
    Am J Med; 1993 May; 94(5):475-482. PubMed ID: 8498392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia.
    Allon M; Takeshian A; Shanklin N
    Kidney Int; 1993 Jan; 43(1):212-7. PubMed ID: 8433561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperkalemia in dialysis patients.
    Ahmed J; Weisberg LS
    Semin Dial; 2001; 14(5):348-56. PubMed ID: 11679104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effect of bicarbonate and insulin with glucose in acute therapy of hyperkalemia in end-stage renal disease patients.
    Kim HJ
    Nephron; 1996; 72(3):476-82. PubMed ID: 8852501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenergic-mediated extrarenal potassium disposal in patients with end-stage renal disease: effect of propranolol.
    Yang WC; Huang TP; Ho LT; Chung HM; Chan YL; Batlle DC
    Miner Electrolyte Metab; 1986; 12(3):186-93. PubMed ID: 2873504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of serum potassium during fasting in patients with end-stage renal disease.
    Gifford JD; Rutsky EA; Kirk KA; McDaniel HG
    Kidney Int; 1989 Jan; 35(1):90-4. PubMed ID: 2651754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure.
    Conte G; Dal Canton A; Imperatore P; De Nicola L; Gigliotti G; Pisanti N; Memoli B; Fuiano G; Esposito C; Andreucci VE
    Kidney Int; 1990 Aug; 38(2):301-7. PubMed ID: 2402122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrarenal potassium homeostasis.
    Bia MJ; DeFronzo RA
    Am J Physiol; 1981 Apr; 240(4):F257-68. PubMed ID: 6111930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a simultaneous potassium and carbohydrate load on extrarenal K homeostasis in end-stage renal failure.
    Alvo M; Krsulovic P; Fernández V; Espinoza AM; Escobar M; Marusic ET
    Nephron; 1989; 53(2):133-7. PubMed ID: 2682302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced insulin sensitivity in extrarenal potassium handling in uremic rats.
    Goecke IA; Bonilla S; Marusic ET; Alvo M
    Kidney Int; 1991 Jan; 39(1):39-43. PubMed ID: 1672173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium and renal failure.
    Kunis CL; Charney AN
    Compr Ther; 1981 Mar; 7(3):29-33. PubMed ID: 7237977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine crises. Hyperkalemia.
    Williams ME
    Crit Care Clin; 1991 Jan; 7(1):155-74. PubMed ID: 2007212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure.
    Blumberg A; Weidmann P; Shaw S; Gnädinger M
    Am J Med; 1988 Oct; 85(4):507-12. PubMed ID: 3052050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prevention of hyperkalemia in end-stage renal disease.
    Allon M
    Kidney Int; 1993 Jun; 43(6):1197-209. PubMed ID: 8315933
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta adrenergic modulation of extrarenal potassium disposal in terminal uraemia.
    Martinez Vea A; Montoliu J; Andreu L; Torras A; Gaya J; López-Pedret J; Revert L
    Proc Eur Dial Transplant Assoc; 1983; 19():756-60. PubMed ID: 6136035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to hyperkalemic end-stage renal disease patients in the emergency department.
    Perazella MA
    Conn Med; 1999 Mar; 63(3):131-6. PubMed ID: 10218288
    [No Abstract]   [Full Text] [Related]  

  • 18. Extrarenal potassium homeostasis with maximal exercise in end-stage renal disease.
    Clark BA; Shannon C; Brown RS; Gervino EV
    J Am Soc Nephrol; 1996 Aug; 7(8):1223-7. PubMed ID: 8866416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired extrarenal disposal of an acute oral potassium load in patients with endstage renal disease on chronic hemodialysis.
    Fernandez J; Oster JR; Perez GO
    Miner Electrolyte Metab; 1986; 12(2):125-9. PubMed ID: 3960016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients.
    Kim HJ
    J Korean Med Sci; 1997 Apr; 12(2):111-6. PubMed ID: 9170015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.